2023 ABSTRACT SUBMISSIONS NOW CLOSED
Abstracts, which may address clinical, epidemiological as well as aspects concerning pathogenesis will be considered in the following categories, now also including COVID-19
Adipocyte biology, insulin resistance
and lipid metabolism |
Clinical management of ADRs |
Aging, frailty, disability &
senescence |
COVID and comorbidities including post acute sequelae of SARS-CoV-2/COVID-19 (PASC), i.e. "long COVID" |
| Body composition and weight change |
Liver disease (incl. viral hepatitis-related), hepatotoxicity |
| Bone metabolism & toxicities |
Other non-infectious comorbidities (incl. cancer, mental health, neurocognitive disorders and renal toxicities, sleep disorders, stress) |
| Cardiovascular disease |
Pulmonary Disease |
Accepted abstracts are selected for either Oral or Poster presentation, at the discretion of the Organizing Committee.
2023 ABSTRACT SUBMISSIONS NOW CLOSED
|
